Advisory Board

Chair

Koen AUGUSTYNS (University of Antwerp, Belgium)

AB Members

Maria Laura BOLOGNESI (University of Bologna, Italy)
Karin BRINER (Novartis, USA)
Anette GRAVEN SAMS (Lundbeck, Denmark)
Herbert WALDMANN (Max Planck Institute of Molecular Physiology, Germany)
Tony WOOD (GlaxoSmithKline, United Kingdom)

The Advisory Board is an EFMC consulting body for the executive committee assisting in assessing the Federation's strategic goals. The tasks of the AB consists of:

advising on EFMC policy related matters internally and externally
proposing novel scientific or political initiatives to the Executive Committee
proposing strategies how to increase awareness of Medicinal Chemistry and support of the community in Europe
proposing strategies how to affect and interact with stakeholders in Europe

The AB is composed of eminent scientists in the life sciences and medicinal chemistry and is chaired by the past president. The EFMC is thankful to all of them for their dedication and valuable contribution.

To see the previous composition of the Advisory Board, please click here